increased and activated phagocytes following cigarette smoke. 3 Therefore, smoking increase levels of oxidative stress, a molecular mechanism which causes damage to human genetic material as telomere attrition. [4] [5] [6] Cigarette smokers have a higher risk of developing several chronic disorders as cardiovascular diseases, several types of cancer or pulmonary diseases. However, not all smokers develop cancer, which indicates a significant interindividual variation in metabolism of tobacco carcinogens and in repair DNA damage. 7 Telomeres are DNA-protein complexes that are composed of TTAGGG repeats and binding proteins. They cap and stabilize the ends of chromosomes, maintaining genome integrity and protecting from damage. 8 Telomeres shorten progressively with cell division owing to incomplete replication of DNA molecules. Telomere length is not only related to the basic biology of aging as a trigger of cellular senescence but also reflects the balance between cytotoxic stressors and antioxidant defense mechanisms. [9] [10] [11] In peripheral blood lymphocytes, telomere length has been demonstrated to differ markedly among humans of the same age. 12 It has been proposed that telomere attrition in circulating white blood cells is a marker for cumulative oxidative stress and inflammation and, therefore, plays a complex role in several pathologies such as cardiovascular disease, pulmonary disease or carcinogenesis. [13] [14] [15] [16] Several reports have indicated that shortening telomere length is accelerated by many other factors in addition to age such us smoking, obesity, physical inactivity, oxidative stress or alcohol intake although some data are conflicting. 5, 9, [17] [18] [19] Smoking implies exposure to a mixture of carcinogenic agents that causes DNA damage, which could be suspected to enhance telomere attrition. The mechanisms for this phenomenon are not yet fully elucidated, but it is known that single stranded DNA breaks caused by oxidative or alkylating agents are less repaired in telomeric sequences than in other parts of genome. 20 In order to maintain genomic integrity, cells possess a complex DNA damage response mechanism, and many enzymes involved in biotransformation of toxicants and cellular defense against toxicant-induced damage to cells have been identified. Polymorphisms of genes encoding such enzymes may significantly modify genotoxic effects of different factors.
The cytochrome P1A1 (CYP1A1) gene codes the enzyme arylhydrocarbon hydroxylase, which is responsible for the metabolism of tobacco procarcinogens like polycyclic aromatic hydrocarbons and aromatic amines. 21 The MspI polymorphism seems to influence the activity of this enzyme, altering the levels of DNA adducts. However, the impact of this genetic variant on risk of endogenous DNA damage is not clear. 22 On the other hand, DNA-repair activities are essential for the protection of the genome from environmental damage such as tobacco smoke. 23 However, contradictory results are often reported by various studies, making it difficult to interpret them. 24, 25 Approximately 160 genes mediate DNA repair have been found in human cells. 26 Several polymorphisms in DNA repair genes contribute to genetic instability and error accumulation due to reduced protein activity being associated to relatively risk of lung cancer in Caucasian population. [27] [28] [29] [30] The nucleotide excision repair pathway repairs DNA damage caused by the tobacco-related carcinogen benzo(a)pyrene, while the base excision repair pathway repairs DNA caused by reactive oxygen species produced by cigarette smoke. 31 In addition, double strand break repair pathway is responsible for repairing double-strand breaks. These results from exogenous agents such as ionizing radiation or environmental carcinogens as those present in tobacco smoke and from endogenous generated reactive oxygen species. 32 Polymorphisms altering DNA repair capacity or carcinogen metabolism may lead to synergistic effects with tobacco carcinogen-induced shorter telomere length independently of cancer interaction. The aim of this study was to explore the association between leukocyte telomere length (LTL) and several genetic polymorphisms in DNA repair genes and carcinogen metabolizers in a cohort of healthy smokers.
Methods

Subject Recruitment and Sample Collection
One hundred forty-five healthy smokers, 68 men and 77 women, (all of Caucasian [Spanish] descent for ≥3 generations) between 25 and 65 years of age were recruited from the Occupational Medicine Committee of Banco Popular, Madrid (Spain) from 2010 to 2013. The present genetic analysis was restricted to Spanish smokers to minimize population stratification. Eligible participants were 25-65 years old and reported smoking at least 1 cigarette per day for at least 5 years. Screening of smokers for study inclusion involved a medical history, clinical examination, electrocardiogram, blood and set of lung function tests. Exclusion criteria included suffer from any illness related to smoking. All participants provided written informed consent in accordance with the principles expressed in the Helsinki Declaration and approval was obtained from the local Ethics Committee (Hospital General Universitario de Guadalajara, Guadalajara, Spain).
All participants completed a questionnaire regarding demographic characteristics, smoking habits, self-reported cigarettes per day (CPD), the number of years the person had smoked and pack years smoked (PYS). Nicotine dependence was assessed with the Fagerstrom Test for Nicotine Dependence. 33 Smoking status was verified by expired carbon monoxide levels.
DNA Extraction
Peripheral blood samples were obtained by venipuncture and we extracted blood leukocyte DNA from the participants using a standard phenol chloroform protocol and performed genotype analyzes in the Biomedicine laboratory of the Universidad Europea, Madrid (Spain). Our study followed recent recommendations for replicating genotype-phenotype association studies. 34 Genotyping was performed specifically for research purposes, and the researchers in charge of genotyping were totally blinded to the participants' identities (blood samples were tracked solely with bar-coding and personal identities were only made available to the main study researcher who was not involved in actual genotyping). The DNA samples were diluted with sterile water and stored at −20°C until analysis.
Telomere Length Analysis
Telomere length was measured using a quantitative PCR-based technique previously described. 35, 36 By this method telomere length is calculated as a ratio between telomere repeat copy By this method telomere length is calculated as a ratio between telomere repeat copy number (T) and a single-copy gene, 36B4, copy number (S). Primers used to amplify telomere repeats and the 36B4 gene were described before 37 . DNA samples were amplified in a total reaction volume of 10 ul containing 1x Power SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA), 300 nM of primer Tel1, 900 nM of primer Tel2, and 30 ng of DNA. For 36B4 reactions the concentrations of primers were 300 nM of 36B4u and 500 nM of 36B4d. All samples, for both telomere and 36B4 amplifications, were analyzed in triplicate using a Step One Plus (Applied Biosystems, Foster City, CA), in 96 well format. For each sample the relative concentration of both Telomere (T) and 36B4
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Polymorphisms Selection and Genotyping
The polymorphisms were selected from genes involved in different DNA repair pathways (APEX nuclease 1, APE1; "Xeroderma pigmentosum" complementation group, XPD and X-ray repair cross complementation group, XRCC1 and XRCC3). Moreover one polymorphism in genes involved in carcinogens metabolism was selected CYP1A1. Chosen polymorphisms were primarily that ones that reported an association between genotypic and phenotypic changes. 28, 38, 39 Polymorphisms of interest were single nucleotide changes (SNPs) in CYP1A1 (Ile462Val), XRCC1 (Arg399Gln), APEX1 (Asp148Glu), XRCC3 (Thr241Met), XPD (Asp312Asn) and (Lys751Gln).
Allelic discrimination analysis was performed with predesigned Life Technologies TaqMan SNP Genotyping Assays on demand for CYP1A1 rs1048943 polymorphism (ID: C_25624888_50), XRCC1 rs25487 polymorphism (ID: C_622564_10), APEX1 rs1130409 polymorphism (ID: C_8921503_10), XRCC3 rs861539 polymorphism (ID: C_8901525_10), XPD rs1799793 polymorphism (ID: C_3145050_10) and for XPD rs13181 polymorphism (ID: C_3145033_10).
PCR amplification was performed using a StepOne Real-Time PCR System (Life Technologies, Foster City, CA) with a denaturation stage at 95°C for 10 minutes, 50 cycles of denaturation at 92°C for 15 seconds, annealing/extension at 60°C for 1 minute, and a final extension stage of 30 seconds at 60°C.
Statistical Analysis
Telomere length was analyzed as a continuous variable and as a categorical variable. Association between age and telomere length was assessed with Spearman rank correlation coefficient. As categorical variable, telomere length was dichotomized at the 33.3% value in first and second-third tertiles. The subjects were categorized into two age groups: less than 40 and at least 40. CPD was also dichotomized at less than 15 and at least 15. Categorized telomere length, smoking status, and genotype frequencies were compared with the chi-square test. The strength of the associations was estimated as odd ratios (ORs) together with 95% confidence intervals (CI) by logistic regression with adjustments for age, smoking habits and gender. Statistical significance refers to at most 0.05 (two-tailed). We also used the chi-square test to assess deviations of genotype distributions from the Hardy-Weinberg equilibrium. All analyses were performed with the PASW/SPSS Statistics 20.0 (SPSS Inc, Chicago, IL) program.
Results
The study participants smoked on average 12.4 CPD, and 53.4% of the study participants were female. The overall mean age was 43.4 years (SD = 11.6). On average they had been smoking for 21.6 years (SD = 11.4) with a nicotine dependence score of 2.6 (SD = 1.9) and their cumulative smoking mean was 13.7 PYS (SD = 11.1). To check the number of CPD reported, the levels of carbon monoxide (parts per million) expired were tested in each smoker.
The overall LTL mean was 1.33 (SD = 0.61) range (0.42-3.45). The frequency of genetic variants analyzed in study group is presented in Table 1 . No differences in genotype distribution between females and males were observed (data not shown). All the single nucleotide polymorphisms were in Hardy-Weinberg equilibrium and showed similar frequency as reported in previous studies in Spanish population. 28 The correlations between LTL and smoking habits in addition to age were assessed in Table 2 . We found a positive correlation between carbon monoxide levels expired and CPD (r = 0.512, P < .001), PYS (r = 0.330, P < .001), or Fagerstrom Test for Nicotine Dependence (r = 0.490, P < .001). As expected, there were significant positive correlations between age and years smoking or PYS (r = 0.878, P < .001; r = 0.612, P < .001), respectively. Also, a negative correlation between age and LTL was found (r = −0.188, P = .023). On the other hand, there was no significant correlation between relative telomere length and exposure biomarkers.
In order to analyze the interactions of smoking habits or DNA repair gene variants with LTL, we used first tertile value of telomere length as the cutoff between long and short telomeres. The subjects were categorized into two age groups: less than 40 and at least 40. Years smoking were categorized in less than 20 and at least 20. CPD and PYS were also dichotomized at less than 20, at least 20 and less than 15, at least 15, respectively. Smokers older than 40 years old presented more than 1.5 times probability having shorter telomeres (being at first tertile) than longers (being at second-third tertiles; P = .014). In addition, we observed a marginally significant relationship between years smoking and LTL (P = .05), subjects smoking for more years showed a lower LTL. However, no interaction between CPD (P = .432) or PYS (P = .551) and LTL was found (Table 3) .
We also analyzed different polymorphisms in enzymes involved in biotransformation of carcinogens as well as DNA repair as susceptibility markers for shorter LTL (Table 3) . Analyses focused on associations with genotype categorized using a dominant model (ie, homozygotes of the most common allele were the referent group, compared to homozygotes plus heterozygotes of the minor allele). Only XRCC1 rs25487 (also referred as Arg399Gln) was associated with increased risk of shorter LTL (P = .038). This value was not Finally, a logistic regression analysis adjusted for age, years smoking, and gender was performed, in order to assess the effect of different polymorphisms on the relative LTL. Analysis showed an association between XRCC1 399Gln allele and shorter telomere length (OR = 5.03, 95% CI = 1.08% to 23.36%). There were not associations between the rest of polymorphisms analyzed and shorter telomere length, APEX1 (Asp148Glu) (OR = 7.39, 95% CI = 0.92% to 59.43%), XRCC3 (Thr241Met) (OR = 1.93, 95% CI = 0.38% to 9.69%), XPD (Asp312Asn) (OR = 1.53, 95% CI = 0.50% to 4.69%), XPD (Lys751Gln) (OR = 1.2, 95% CI = 0.38% to 3.77%) and CYP1A1 (Ile462Val) (OR = 1.96, 95% CI = 0.77% to 4.91%).
Discussion
Smoking implies exposure to a mixture of carcinogenic agents that causes DNA damage, which could be suspected to enhance telomere attrition. 4, 5 To protect and deal with DNA damage cells possess mechanisms that repair and neutralize harmful substances. In this study we investigated the association between LTL and several genetic polymorphisms in DNA repair genes and carcinogen metabolizers in a cohort of healthy smokers. Since our knowledge, only one study evaluates the effect of DNA repair variants on LTL and not in a cohort of healthy smokers. Notwithstanding, they didn't evaluate the individual effect of DNA repair variant on LTL, they analyzed the joint effect of smoking and LTL for cancer risk. 40 Previous studies have shown that telomere length is shorter in peripheral blood leukocytes of smokers compared with nonsmokers. 5, 18, 41 Most of that analyze LTL in lung disease population, reporting an additive association between LTL and smoking on cancer development. 40, 42 On the other hand, the interaction between LTL and smoking history is not clear. 40, 43 In our study, we didn't find any relationship between smoking history measured as CPD or PYS and shorter LTL in healthy smoker population. We only found a negative correlation between years smoking and telomere length. A possible explanation is that reported high levels of smoking may not increase toxin exposure levels proportionally or at the rate observed at lower levels of smoking, moreover epidemiologic studies suggest that there is no safe level of smoking. Smoking abstinence is an important goal because even low levels of smoking are associated with significant toxin exposure. 44 We also analyzed the impact of polymorphisms of DNA repair genes and CYP1A1 on LTL. Our results showed that among the genes, XRCC1 399Gln allele was marginally associated with shorter telomere length. The increased risk was approximately fivefold adjusted by age, gender and smoking history. The XRCC1 Arg399Gln polymorphism has been associated with reduced DNA repair efficiency. [45] [46] [47] [48] There is no data on the impact of this variant on LTL, however analysis of chromosome aberrations and micronucleus have been developed. Smokers and nonsmokers with the 399Gln allele have shown higher frequency of chromosome aberrations than those with the wild type allele. 38, 39, 49 In addition, some variants of XRCC1 and XPD genes have been associated to cellular DNA damage measured by comet assay in peripheral blood leukocytes. 45, 50 These results are in agreement with previous published studies which have demonstrated that individuals with short telomeres were more likely to exhibit chromosome instability. 51, 52 An important goal of our study is the analysis of the effect of variants on LTL in healthy smokers, avoiding the possible interaction with cancer pathogenesis. We found a significant difference in telomere shorten sensitivity between smokers with the XRCC1 399Gln allele and the wild type genotype. Smokers with the XRCC1 399Gln allele exhibited significantly shorter telomeres. This suggest that smokers with the XRCC 399Gln allele could be predisposed to a greater risk for developing cancer, given the well-established association between reduced LTL and cancer risk. [13] [14] [15] [16] The SNP-smoking interaction reducing repair could only be important in presence of smoking exposure. This gene-smoking interaction is consistent with previous reports. [53] [54] [55] A plausible biological explanation for such interaction is that, in smokers, continuous exposure to tobacco smoke compounds could stimulate the DNA repair activity, making the effect of the polymorphisms that reduce repair capacity more pronounced. Thus, the presence of polymorphisms that result in a decreased DNA repair activity could lead to more extended genetic damage in such smokers compared with nonsmokers. 55 In summary, despite of the small sample size of the current study, our data provide evidence that XRCC1 399Gln allele appears to confer sensitivity to the effects of tobacco compounds on LTL. Larger studies are needed to confirm our initial findings, analyzing the function of smoking-induced DNA-repair genes and telomere length in order to identify therapeutic targets to treat smokinginduced diseases.
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